
Adverse reaction signal ratio imbalance analysis of the rare disease drug efgartigimod α based on the FDA adverse event reporting system database
Lingna GAO, Zongyun LI, Xiaoli ZHU, Jingzhe HAN
Clinical Medication Journal ›› 2025, Vol. 23 ›› Issue (8) : 74-80.
Adverse reaction signal ratio imbalance analysis of the rare disease drug efgartigimod α based on the FDA adverse event reporting system database
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |